Literature DB >> 32130627

Distinct trajectories of moderate to vigorous physical activity and sedentary behavior following a breast cancer diagnosis: the Pathways Study.

Zaixing Shi1,2,3,4, Andrew Rundle5,6, Jeanine M Genkinger5,6, Ying Kuen Cheung5,6, Isaac J Ergas7, Janise M Roh7, Lawrence H Kushi7, Marilyn L Kwan7, Heather Greenlee8,5,9,10.   

Abstract

PURPOSE: To identify distinct trajectories of total moderate-to-vigorous physical activity (MVPA) and sedentary behavior following a breast cancer diagnosis and their correlates.
METHODS: The analysis examined 3000 female breast cancer survivors within Kaiser Permanente Northern California between 2006 and 2013. Self-reported time spent on total MVPA and sedentary behaviors were assessed at baseline (mean = 1.8 months post-diagnosis) and at 6 and 24 months follow up. Trajectory groups were identified using group-based trajectory modeling and K-means for longitudinal data analysis. Trajectory groups were named by baseline activity level (high, medium, or low) and direction of change (increaser, decreaser, or maintainer).
RESULTS: Trajectory analyses identified three MVPA trajectories [high decreaser (7%), medium decreaser (35%), low maintainer (58%)] and four sedentary behavior trajectories [high maintainer (18%), high decreaser (27%), low increaser (24%), and low maintainer (31%)]. Women with higher education (ORs: 1.63-4.37), income (OR: 1.37), dispositional optimism (ORs: 1.60-1.86), and social support (OR: 1.33) were more likely to be high or medium decreasers of MVPA (all P < 0.05). High maintainers and high decreasers of sedentary behavior were more likely to have higher education (OR: 1.84) and social support (ORs: 1.42-1.86), but lower income (OR: 0.66; all P < 0.05).
CONCLUSIONS: In the 24 months following breast cancer diagnosis, 42% of survivors decreased MVPA and 73% maintained or increased time on sedentary behavior. Socioeconomic status and stress coping at diagnosis predicted subsequent PA trajectory. IMPLICATIONS FOR CANCER SURVIVORS: It is important to prioritize exercise intervention and counseling during early stage of breast cancer survivorship, especially in survivors who are at high risk of becoming physically inactive post-diagnosis.

Entities:  

Keywords:  Breast cancer; Cancer survivors; Group-based trajectory modeling; K-means; Physical activity; Trajectory analysis

Mesh:

Year:  2020        PMID: 32130627     DOI: 10.1007/s11764-020-00856-0

Source DB:  PubMed          Journal:  J Cancer Surviv        ISSN: 1932-2259            Impact factor:   4.442


  5 in total

1.  Resistance training in breast cancer patients undergoing primary treatment: a systematic review and meta-regression of exercise dosage.

Authors:  Pedro Lopez; Daniel A Galvão; Dennis R Taaffe; Robert U Newton; Giovani Souza; Gabriel S Trajano; Ronei S Pinto
Journal:  Breast Cancer       Date:  2020-08-19       Impact factor: 4.239

2.  Effects of heavy-load resistance training during (neo-)adjuvant chemotherapy on muscle cellular outcomes in women with breast cancer.

Authors:  Emelie Strandberg; Karianne Vassbakk-Svindland; Anna Henriksson; Birgitta Johansson; Olav Vikmoen; David Kudrén; Tim Schauer; Henrik Lindman; Fredrik Wärnberg; Sveinung Berntsen; Ingrid Demmelmaier; Karin Nordin; Truls Raastad
Journal:  Medicine (Baltimore)       Date:  2021-03-12       Impact factor: 1.817

3.  Choosing the right time granularity for analysis of digital biomarker trajectories.

Authors:  Nicole I Wakim; Thomas M Braun; Jeffrey A Kaye; Hiroko H Dodge
Journal:  Alzheimers Dement (N Y)       Date:  2020-12-18

4.  Limited Changes in Lifestyle Behaviours after Non-Muscle Invasive Bladder Cancer Diagnosis.

Authors:  Ivy Beeren; Liesbeth de Goeij; Rana Dandis; Nikoletta Vidra; Moniek van Zutphen; J Alfred Witjes; Ellen Kampman; Lambertus A L M Kiemeney; Alina Vrieling
Journal:  Cancers (Basel)       Date:  2022-02-15       Impact factor: 6.639

Review 5.  Psychosocial Determinants of Lifestyle Change after a Cancer Diagnosis: A Systematic Review of the Literature.

Authors:  Meeke Hoedjes; Inge Nijman; Chris Hinnen
Journal:  Cancers (Basel)       Date:  2022-04-16       Impact factor: 6.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.